- Preface
- List of abbreviations
- Chapter 1 Mechanisms of action and resistance to modern antibacterials, with a history of their development
- Chapter 2 Inhibitors of bacterial cell wall synthesis
- Chapter 3 Inhibitors of bacterial protein synthesis
- Chapter 4 Synthetic antibacterial agents and miscellaneous antibiotics
- Chapter 5 Antiviral agents
- Chapter 6 Antiretroviral agents
- Chapter 7 Drugs used in the treatment of viral hepatitis
- Chapter 8 Antifungal agents
- Chapter 9 Antiprotozoal and anthelminthic agents
- Chapter 10 The problem of resistance
- Chapter 11 The genetics and mechanisms of acquired resistance
- Chapter 12 Laboratory investigations and the treatment of infection
- Chapter 13 General principles of the treatment of infection
- Chapter 14 Pharmacokinetic and pharmacodynamic principles
- Chapter 15 Prescribing in special groups: effects of age, pregnancy, body weight, and hepatic and renal impairment
- Chapter 16 OPAT: outpatient parenteral antimicrobial therapy
- Chapter 17 Adverse drug reactions, and patient safety
- Chapter 18 Chemoprophylaxis and immunization
- Chapter 19 Guidelines, formularies, and antimicrobial policies
- Chapter 20 Antimicrobial stewardship, surveillance of antimicrobial consumption, and its consequences
- Chapter 21 Respiratory tract infections
- Chapter 22 Topical use of antimicrobial agents
- Chapter 23 Urinary tract infections
- Chapter 24 Sexually transmitted infections
- Chapter 25 Gastrointestinal infections
- Chapter 26 Serious bacterial bloodstream infections
- Chapter 27 Bone and joint infections
- Chapter 28 Infections of the central nervous system
- Chapter 29 Skin and soft-tissue infections
- Chapter 30 Tuberculosis and other mycobacterial diseases
- Chapter 31 Infections in immunocompromised patients, including HIV/AIDS
- Chapter 32 Viral infections
- Chapter 33 Management of HIV infection
- Chapter 34 Treatment of chronic viral hepatitis
- Chapter 35 Parasitic disease
- Chapter 36 The development and marketing of antimicrobial drugs
- Appendix: Recommendations for Further Reading
- Index
(p. 178) Chemoprophylaxis and immunization
- Chapter:
- (p. 178) Chemoprophylaxis and immunization
- Author(s):
Peter Davey
, Mark Wilcox
, William Irving
, and Guy Thwaites
- DOI:
- 10.1093/med/9780199689774.003.0018
Infection can be prevented using antimicrobial agents (chemoprophylaxis) or vaccines (immunization), remembering that prevention is better than cure. This chapter reviews the key factors that determine when and how chemoprophylaxis should be used, particularly which factors, such as timing of administration of antibiotics, and surgery type and setting, affect the efficacy of this approach. Antibiotic prophylaxis is indicated in many but importantly not all surgical operations. As well as reducing infection risk, judicious use of prophylaxis may decrease overall antibiotic consumption. Non-surgical settings where antimicrobial agents are used to prevent infection are also discussed, including intrapartum antibiotic prophylaxis and use of selective decontamination of the digestive tract in critically ill patients. Finally, the expanding use of immunization in childhood, adolescence, and adulthood is reviewed, noting that coverage (compliance) in the at-risk populations is crucial in determining the overall effectiveness of vaccines.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Preface
- List of abbreviations
- Chapter 1 Mechanisms of action and resistance to modern antibacterials, with a history of their development
- Chapter 2 Inhibitors of bacterial cell wall synthesis
- Chapter 3 Inhibitors of bacterial protein synthesis
- Chapter 4 Synthetic antibacterial agents and miscellaneous antibiotics
- Chapter 5 Antiviral agents
- Chapter 6 Antiretroviral agents
- Chapter 7 Drugs used in the treatment of viral hepatitis
- Chapter 8 Antifungal agents
- Chapter 9 Antiprotozoal and anthelminthic agents
- Chapter 10 The problem of resistance
- Chapter 11 The genetics and mechanisms of acquired resistance
- Chapter 12 Laboratory investigations and the treatment of infection
- Chapter 13 General principles of the treatment of infection
- Chapter 14 Pharmacokinetic and pharmacodynamic principles
- Chapter 15 Prescribing in special groups: effects of age, pregnancy, body weight, and hepatic and renal impairment
- Chapter 16 OPAT: outpatient parenteral antimicrobial therapy
- Chapter 17 Adverse drug reactions, and patient safety
- Chapter 18 Chemoprophylaxis and immunization
- Chapter 19 Guidelines, formularies, and antimicrobial policies
- Chapter 20 Antimicrobial stewardship, surveillance of antimicrobial consumption, and its consequences
- Chapter 21 Respiratory tract infections
- Chapter 22 Topical use of antimicrobial agents
- Chapter 23 Urinary tract infections
- Chapter 24 Sexually transmitted infections
- Chapter 25 Gastrointestinal infections
- Chapter 26 Serious bacterial bloodstream infections
- Chapter 27 Bone and joint infections
- Chapter 28 Infections of the central nervous system
- Chapter 29 Skin and soft-tissue infections
- Chapter 30 Tuberculosis and other mycobacterial diseases
- Chapter 31 Infections in immunocompromised patients, including HIV/AIDS
- Chapter 32 Viral infections
- Chapter 33 Management of HIV infection
- Chapter 34 Treatment of chronic viral hepatitis
- Chapter 35 Parasitic disease
- Chapter 36 The development and marketing of antimicrobial drugs
- Appendix: Recommendations for Further Reading
- Index